Topics:
Hematologic Malignancies • Medical Oncology • Myeloma • NCI-CCC Tumor Board Question • Mayo Clinic • NCI-CCC Myeloma Tumor Board Question • Multiple Myeloma
What is your approach for using anticoagulation/aspirin in patients with multiple myeloma?
Answer from: Medical Oncologist at Academic Institution
Excellent question with lots of nuances but no clear answer. I'll start with my gestalt approach, which is to consider a DOAC for every patient with myeloma if all of the following are true:
They are receiving an IMiD (lenalidomide or pomalidomide)
They set off my 'spidey sense' with one or more o...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
@Rahul Banerjee has done a wonderful job here.
My practice is to start a prophylactic dose DOAC (apixaban 2.5 mg BID, rivaroxaban 10 mg daily) for essentially all patients with newly diagnosed myeloma. This is in part because we frequently employ quadruplets and/or cafilzomib-based regimens. ...
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Excellent addition as always! I should add that al...
Excellent addition as always! I should add that al...
Medical Oncologist at Winship Cancer Institute of Emory University
I have literally no spider sense and am very concr...
I have literally no spider sense and am very concr...
Medical Oncologist at University of Chicago
I try not to overthink this. Patients with myeloma...
I try not to overthink this. Patients with myeloma...